About DPB Antibiotics
DPB Antibiotics is a Healthcare company based in Mumbai (India) founded in 2005. It specializes in the manufacturing and supplying of active pharmaceutical ingredients (APIs). It operates on a B2B model. Its Indian entity Dpb Pharmaceuticals Limited reported revenue of ₹223 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Supply. Its competitors include Del Trade, Globofarm International, HUFORT HEALTHCARE, Nishchem and Pals Pharma and 2 more.
Company details
DPB Antibiotics, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api supply. Specializes in the manufacturing and supplying of active pharmaceutical ingredients (APIs). Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website dpbantibiotics.com
- Legal Name Dpb Pharmaceuticals Limited
- Date of Incorporation 20 Apr, 2018
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹223 Cr
FY 2024 · +18% YoY
- Net Profit₹12.31 Cr
FY 2024 · 6% margin
- EBITDA₹12.04 Cr
FY 2024 · 5% margin
Associated legal entities of DPB Antibiotics
DPB Antibiotics operates through Dpb Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dpb Pharmaceuticals Limited CIN U24304MH2018PLC308316 | Active | 20 Apr 2018 | Mumbai, Maharashtra | ₹223 Cr | – | 3 | View details |
Board of directors of Dpb Pharmaceuticals Limited (DPB Antibiotics)
Dpb Pharmaceuticals Limited is the primary company behind DPB Antibiotics. The board of Dpb Pharmaceuticals Limited currently have 3 directors; the longest-serving is Devang Manharlal Ajmera, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Devang Manharlal Ajmera DIN 02366861 | Director | 20 Apr 2018 | 8 yrs 5 mo | Dpb Pharmaceuticals Limited |
| Piyush Manharlal Ajmera DIN 02366873 | Director | 20 Apr 2018 | 8 yrs 5 mo | Dpb Pharmaceuticals Limited |
| Bhavin Manharlal Ajmera DIN 02366882 | Director | 20 Apr 2018 | 8 yrs 5 mo | Dpb Pharmaceuticals Limited |
Financials of DPB Antibiotics
Figures of Dpb Pharmaceuticals Limited, the primary company behind DPB Antibiotics, for FY 2024. Revenue was ₹223 Cr (+18% year on year). Net profit was ₹12.31 Cr (6% margin). EBITDA was ₹12.04 Cr (5% margin). Revenue has grown at a compounded annual rate of +51% over three years.
- ₹223 CrRevenue · FY 2024 · +18% YoY
- ₹12.31 CrNet profit · 6% margin
- ₹12.04 CrEBITDA · 5% margin
- ₹3.13 CrPaid-up capital
- +51%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Dpb Pharmaceuticals Limited are on its company page.
Detailed financial statements for DPB Antibiotics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of DPB Antibiotics
DPB Antibiotics has 7 listed competitors in our database. They include Del Trade, Globofarm International, HUFORT HEALTHCARE, Nishchem and Pals Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| deltrade.in | 2010 | Delhi, India | – | 76 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| globofarm.net | 2014 | Mumbai, India | – | – | Manufactures and supplies pharmaceutical ingredients and wellness products worldwide. | |
| hufort.in | 2007 | Mumbai, India | – | 6 | Distributes pharmaceutical raw materials through import, stock, and sales services. | |
| nishchem.com | 1990 | Mumbai, India | – | 15 | Manufactures and distributes pharmaceutical APIs and formulations globally with import and export services. | |
| palspharma.co.in | 2013 | Mumbai, India | – | – | Sourcing and marketing of pharmaceutical ingredients and products worldwide. | |
| jbkhokhani.com | 1965 | Mumbai, India | – | – | Distributes active pharmaceutical ingredients to industry clients. | |
| shaivyapharmachem.co.in | 2020 | Surat, India | – | – | Distributes pharmaceutical raw materials, intermediates, and chemicals worldwide. |
Detailed competitors of DPB Antibiotics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as DPB Antibiotics (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DPB Antibiotics
DPB Antibiotics was founded in 2005.
DPB Antibiotics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind DPB Antibiotics, Dpb Pharmaceuticals Limited, reported revenue of ₹223 Cr for FY 2024, up 18% year on year.
DPB Antibiotics, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api supply. Specializes in the manufacturing and supplying of active pharmaceutical ingredients (APIs). Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
DPB Antibiotics's top competitors include Del Trade, Globofarm International and HUFORT HEALTHCARE.
DPB Antibiotics operates through Dpb Pharmaceuticals Limited.
The legal entities of DPB Antibiotics currently have 3 directors, including Devang Manharlal Ajmera, Piyush Manharlal Ajmera, Bhavin Manharlal Ajmera.